Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.77% is 40% above its 5-year average of 2.69%, near the high end of its 5-year range (1.32%–3.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.94% above its 12-month average of 3.66%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.77%.
DEBT TO ASSETS RATIO
3.77%
DEBT TO ASSETS RATIO AVG TTM
3.66%
DEBT TO ASSETS RATIO AVG 3Y
3.11%
DEBT TO ASSETS RATIO AVG 5Y
2.69%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+2.94%
CURRENT VS 3Y AVG
+20.98%
CURRENT VS 5Y AVG
+40.02%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 843 covered companies
CURRENT VS SECTOR MEDIAN
+4086.25%
vs the sector median at left
Market Cap
$2.03B
Debt to Assets Ratio
0.73%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.02B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.05B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.06B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.98B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Progyny, Inc. (PGNY) | $2.03B | 3.77% | 3.66% | 3.11% | 2.69% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.03B | 0.73% | N/A | N/A | N/A |
| UroGen Pharma Ltd. (URGN)vs › | $2.03B | 0.78% | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 0.08% | N/A | N/A | N/A |
| Fortrea Holdings Inc. (FTRE)vs › | $2.05B | 0.41% | N/A | N/A | N/A |
| Alvotech (ALVO)vs › | $2.06B | 0.91% | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | 0.01% | N/A | N/A | N/A |
| Vericel Corporation (VCEL)vs › | $2.07B | 0.18% | N/A | N/A | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.98B | 0.03% | N/A | N/A | N/A |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.10B | 0.01% | N/A | N/A | N/A |
Debt/Assets
3.8%
Debt/Equity
0.06
Current Ratio
2.14
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.77% |
| 2026-03-31 | 3.91% |
| 2025-12-31 | 3.73% |
| 2025-09-30 | 3.54% |
| 2025-06-30 | 3.35% |
| 2025-03-31 | 3.56% |
| 2024-12-31 | 3.17% |
| 2024-09-30 | 2.52% |
| 2024-06-30 | 2.84% |
| 2024-03-31 | 2.43% |
| 2023-12-31 | 2.56% |
| 2023-09-30 | 2.44% |
| 2023-06-30 | 2.66% |
| 2023-03-31 | 2.84% |
| 2022-12-31 | 1.42% |
| 2022-09-30 | 1.32% |
| 2022-06-30 | 1.50% |
| 2022-03-31 | 1.73% |
| 2021-12-31 | 2.42% |
| 2021-09-30 | 2.27% |
| 2021-06-30 | 2.52% |
| 2021-03-31 | 2.75% |
| 2020-12-31 | 3.76% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 4.95% |
| 2019-03-31 | 11.45% |
| 2018-12-31 | 0.61% |
